Inovalon announced that it has entered into an agreement with Boehringer Ingelheim Pharmaceuticals Inc. The agreement utilizes Inovalon and Avalere’s combined breadth of healthcare capabilities and integrated platform supporting greater customer insight, data integration and analytics and integrated provider and patient-level intervention capabilities. This will support outcomes-based contracting and help translate clinical outcomes into real world practice to ultimately improve patient clinical care. The partnership recognizes that the healthcare landscape continues to rapidly transform from fee-for-service and volume to value and outcomes. By leveraging innovative technologies currently in use with more than 100 existing customers, the partnership will leverage a more holistic and integrated support to outcomes based contracting that will better align with payor needs and help improve quality and clinical/economic outcomes.